Social mixing with other children during infancy enhances antibody response to a pneumococcal conjugate vaccine in early childhood

被引:20
|
作者
Salt, Penny
Banner, Carly
Oh, Sarah
Yu, Ly-mee
Lewis, Susan
Pan, Dingxin
Griffiths, David
Ferry, Berne
Pollard, Andrew
机构
[1] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford Vaccine Grp, Oxford OX3 9DU, England
[2] Churchill Hosp, Dept Immunol, Oxford OX3 7LJ, England
[3] Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX3 9DU, England
[4] Univ Oxford, John Radcliffe Hosp, Acad Dept Microbiol & Infect Dis, Oxford OX3 9DU, England
关键词
D O I
10.1128/CVI.00344-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Children who have siblings and/or who attend day care have higher rates of nasopharyngeal colonization with pneumococci than lone children do. Pneumococcal colonization is usually asymptomatic but is a prerequisite for invasive disease. We studied the effect of social mixing with other children on immunity to a pneumococcal vaccine. One hundred sixty children aged I year were immunized with a 7-valent conjugate pneumococcal vaccine. A blood sample was obtained before and 9 to 11 days after the vaccine. The concentration and avidity of antibody against vaccine pneumococcal serotypes (4,613, 9V, 14, 18C, 19F, and 23F) were studied in relation to pneumococcal carriage rate and measures of social mixing. Children with increased social mixing had higher antibody concentrations against serotypes 4, 9V, 14, and 23F than lone children did. The least-carried serotype, serotype 4, was the one of the most immunogenic. This contrasts with serotype 6B, the most common nasopharyngeal isolate but the least immunogenic. Social mixing in infancy enhances the immune response to a Streptococcus pneumoniae polysaccharide-protein conjugate vaccine at 1 year of age. Exposure to pneumococci in the first year of life may induce immunological priming. An alternative explanation is that differences in immunological experience, such as increased exposure to respiratory viral infections in early childhood, alters the response to vaccines perhaps by affecting the balance between Th1 and Th2 cytokines. The low immunogenicity of serotype 6B polysaccharide might make conditions more favorable for carriage of the 6B organism and explain why 6B pneumococci were more frequently isolated than other serotypes.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 50 条
  • [41] ANTIBODY-RESPONSE TO PNEUMOCOCCAL VACCINE (PV) IN ASPLENIC CHILDREN WITH HODGKINS-DISEASE
    IMBODEN, L
    WEINER, L
    SCHIFFMAN, G
    PEDIATRIC RESEARCH, 1979, 13 (04) : 449 - 449
  • [42] Persistence of protective antibody concentrations and response to a booster among children given hepatitis A vaccine during infancy: Effect of maternal antibody status
    Fiore, AE
    Shapiro, C
    Sabin, KM
    Labonte, K
    Bell, BP
    Margolis, HS
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1153 - 1153
  • [43] Vaccination with the heptavalent pneumococcal conjugate vaccine Prevenar™ provides early protective antibody responses in children after allogeneic stem cell transplantation.
    Meisel, R
    Dirksen, U
    Schubert, R
    Gruhn, B
    Strauss, G
    Duffner, U
    Groll, A
    Beutel, K
    Bluetters-Sawatzki, R
    Holter, W
    Feuchtinger, T
    Gruettner, HP
    Zielen, S
    Laws, HJ
    Dilloo, D
    BLOOD, 2005, 106 (11) : 29A - 29A
  • [44] ANTIBODY-RESPONSE TO PNEUMOCOCCAL VACCINE IN CHILDREN RECEIVING BONE-MARROW TRANSPLANTATION
    AVANZINI, MA
    CARRA, AM
    MACCARIO, R
    ZECCA, M
    PIGNATTI, P
    MARCONI, M
    COMOLI, P
    BONETTI, F
    DESTEFANO, P
    LOCATELLI, F
    JOURNAL OF CLINICAL IMMUNOLOGY, 1995, 15 (03) : 137 - 144
  • [45] HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE (7-OMPC) PRIMES FOR ANTIBODY-RESPONSE TO PURE POLYSACCHARIDE PNEUMOCOCCAL VACCINE FOLLOWING TREATMENT FOR HODGKINS-DISEASE
    CHAN, C
    MOLRINE, D
    GEORGE, S
    GOORIN, A
    TARBELL, N
    MAUCH, P
    DILLER, L
    PHILLIPS, N
    AMBROSINO, D
    PEDIATRIC RESEARCH, 1995, 37 (04) : A171 - A171
  • [46] LONGITUDINAL ASSESSMENT OF ANTIBODY-RESPONSE OF CHILDREN WITH RENAL-DISEASE TO PNEUMOCOCCAL VACCINE
    DRUCKER, RP
    MOGGIO, MV
    HARRIS, RE
    SCHIFFMAN, G
    WILFERT, CM
    PEDIATRIC RESEARCH, 1985, 19 (04) : A291 - A291
  • [47] Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
    Molrine, DC
    Antin, JH
    Guinan, EC
    Soiffer, RJ
    MacDonald, K
    Malley, R
    Malinoski, F
    Trocciola, S
    Wilson, M
    Ambrosino, DM
    BLOOD, 2003, 101 (03) : 831 - 836
  • [48] Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants
    Puumalainen, T
    Zeta-Capeding, MR
    Käyhty, H
    Lucero, MG
    Auranen, K
    Leroy, O
    Nohynek, H
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (04) : 309 - 314
  • [49] Antibody Response to Pneumococcal Conjugate Vaccine (PCV13) in Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib
    Andrick, Benjamin
    Alwhaibi, Abulrahman
    DeRemer, David
    Quershi, Sameera
    Khan, Rahil
    Shenoy, Somanath
    Pantin, Jeremy M.
    BLOOD, 2016, 128 (22)
  • [50] Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
    Angoulvant, F.
    Levy, C.
    Grimprel, E.
    Varon, E.
    Lorrot, M.
    Biscardi, S.
    Minodier, P.
    Dommergues, M. A.
    Hees, L.
    Gillet, Y.
    Craiu, I.
    Zenkhri, F.
    Dubos, F.
    Gras-Le Guen, C.
    Launay, E.
    Martinot, A.
    Cohen, R.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (07) : 918 - 924